It was also found that overexpression of BUB1 was tightly associated with the development and progression of several human cancers, including breast cancer, prostate cancer, and hepatocellular carcinomas, as well as lymphoma and ovarian cancer [13–17]. Here, BUB1 is linked to breast cancer.